TMO Stock Up 20% after 5-Day Win Streak
Thermo Fisher Scientific (TMO) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 20% return. The company has gained about $36 Bil in value over the last 5 days, with its current market capitalization at about $183 Bil. The stock remains 6.6% below its value at the end of 2024. This compares with year-to-date returns of 8.6% for the S&P 500.
Comparing TMO Stock Returns With The S&P 500
The following table summarizes the return for TMO stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | TMO | S&P 500 |
|---|---|---|
| 1D | 1.4% | 0.0% |
| 5D (Current Streak) | 19.8% | 1.3% |
| 1M (21D) | 17.7% | 4.1% |
| 3M (63D) | 14.4% | 15.6% |
| YTD 2025 | -6.6% | 8.6% |
| 2024 | -1.7% | 23.3% |
| 2023 | -3.4% | 24.2% |
| 2022 | -17.3% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 42 S&P constituents with 3 days or more of consecutive gains and 69 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 9 | 47 |
| 4D | 12 | 20 |
| 5D | 10 | 1 |
| 6D | 7 | 1 |
| 7D or more | 4 | 0 |
| Total >=3 D | 42 | 69 |
Key Financials for Thermo Fisher Scientific (TMO)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $42.9 Bil | $42.9 Bil |
| Operating Income | $7.3 Bil | $7.7 Bil |
| Net Income | $6.0 Bil | $6.3 Bil |
Last 2 Fiscal Quarters:
| Metric | 2024 FQ4 | 2025 FQ1 |
|---|---|---|
| Revenues | $11.4 Bil | $10.4 Bil |
| Operating Income | $2.2 Bil | $1.8 Bil |
| Net Income | $1.8 Bil | $1.5 Bil |
While TMO stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.